Traws Pharma, Inc. 8-K Filing
Ticker: TRAW · Form: 8-K · Filed: Dec 16, 2025 · CIK: 1130598
| Field | Detail |
|---|---|
| Company | Traws Pharma, Inc. (TRAW) |
| Form Type | 8-K |
| Filed Date | Dec 16, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $2.33 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Traws Pharma, Inc. (ticker: TRAW) to the SEC on Dec 16, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $2.33 (. The Options have an exercise price of $2.33 per share (the closing price of the Com).
How long is this filing?
Traws Pharma, Inc.'s 8-K filing is 2 pages with approximately 556 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 556 words · 2 min read · ~2 pages · Grade level 13.2 · Accepted 2025-12-16 17:00:36
Key Financial Figures
- $2.33 — . The Options have an exercise price of $2.33 per share (the closing price of the Com
Filing Documents
- tm2533625d1_8k.htm (8-K) — 23KB
- 0001104659-25-121635.txt ( ) — 183KB
- tmb-20251212.xsd (EX-101.SCH) — 3KB
- tmb-20251212_lab.xml (EX-101.LAB) — 33KB
- tmb-20251212_pre.xml (EX-101.PRE) — 22KB
- tm2533625d1_8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 16, 2025 TRAWS PHARMA, INC. By: /s/ Iain Dukes Iain Dukes Chief Executive Officer